about
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis.Oxidative, metabolic, and apoptotic responses of Schwann cells to high glucose levels.Peroxisome determination in optical microscopy: a useful tool derived by a simplification of an old ultrastructural technique.The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators.Pain relieving and protective effects of Astragalus hydroalcoholic extract in rat arthritis models.In vitro and in vivo characterisation of the bifunctional MOP/DOP ligand UFP-505.Efficacy of isothiocyanate-based compounds on different forms of persistent painBioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid ArthritisNanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome modelIntra-articular mucilages: behavioural and histological evaluations for a new model of articular painSynthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid ArthritisResearching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal OriginPhaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in MiceEruca sativa Meal against Diabetic Neuropathic Pain: An H2S-Mediated Effect of GlucoerucinEffect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis
P50
Q37228227-1122F21F-2092-484B-82EB-62D91EC040E8Q38909374-706CC2C0-EB4B-4CF8-89F7-C336E4FC8E9EQ39009994-5E401FB4-7133-47D5-A7AA-86B5BC4603A1Q48056690-0CAC0623-D59D-4F5E-B350-6C6AC6B56A77Q48120525-C54FEFB4-78B3-4FC8-98A9-0237A5A545DFQ48273101-A2159E6F-6EC2-4192-ADF9-DFB9AA1D30D9Q51741932-C247202D-E917-4AD5-92AB-9C7E2D57BB8CQ59033869-DB388F52-F0AF-4D14-9332-9D9449ACCCD8Q91122100-C4903C58-7F7A-4D46-973E-56BBFF1B4588Q91246492-AFC8B82A-8A6A-4103-892B-FBABAF7A704AQ91734321-A13BF733-E234-44FB-B4BD-AE002890E2B4Q91738400-E3B2D69D-CD84-40AD-843C-CC2985FB1936Q92156587-7F099F41-A162-4B78-972A-D6479F226C12Q92373003-08CCE97D-C126-4E52-9756-429749726E55Q92731233-86072861-06A3-49F3-8510-A7BC1290A84EQ93053266-59B6BE13-1C2A-444E-B743-4AD73475A496
P50
description
researcher (ORCID 0000-0001-8834-5801)
@en
name
Laura Micheli
@en
type
label
Laura Micheli
@en
prefLabel
Laura Micheli
@en
P31
P496
0000-0001-8834-5801